Applied Clinical Trials-12-01-2014

The drug industry has seen an increasing movement to leverage mobile technology to engage with patients and collect their data during clinical trials.

It is tempting to imagine the use of the patient's own mobile computing platform for collection of patient-reported outcomes (PROs).

The promise is that customized delivery of injectible drugs and biologics will reduce toxicity, enhance individual response, facilitate the delivery of multiple drugs, minimize waste, and encourage patient adherence to prescribed treatment.

In a health policy world where competition for profile is tough, a vacuum at the top is a serious disadvantage.

As the importance of translational research continues to grow, research institutions are exploring other options to remain competitive players in the academic clinical research arena.

The Future of ePRO Collection Mobile Customization Strategies Academic Research and CTMS Also in this issue: New Combination Drug Challenges Clinical Research Perceptions in Europe Key Benefits of Investigator Portals